Drug exposure The study cohort consisted of new users of GLP-1RAs (dulaglutide, exenatide, liraglutide, lixisenatide or semaglutide), SGLT2 inhibitors (canagliflozin, dapagliflozin or empagliflozin), metformin and other second- or third-line glucose-lowering drugs (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, sulfonylureas, meglitinides, -glucosidase inhibitors, insulin or a combination of glucose-lowering drugs)
- The FDA warns against using compounded formulations of GLP1 medications, which sometimes use forms of drug that have not been properly tested for safety or effectiveness.
Compounded GLP-1 or compounded tirzepatide formulations, when prescribed, must be obtained from properly licensed compounding pharmacies in accordance with applicable federal and state regulations
Thats when I decided that it was time to try something different and got on the GLP-1 with Ro. What is WADAs stance on GLP-1s like Zepbound